https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0716-10182000000300001
Emergencia del síndrome cardiopulmonar por hantavirus en las Américas

EDITORIAL 

GREGORY J. MERTZ,1 PABLO A. VIAL 2 

EMERGENCE OF HANTAVIRUS CARDIOPULMONARY SYNDROME       IN THE AMERICAS 

 El hantavirus se reconoció por primera vez en 1993    como el agente causal de una enfermedad severa en seres humanos en América.    En mayo de 1993, en el Sur-Oeste de los Estados Unidos de Norte América    (E.U.A.), se observó la aparición de un número inusual    de casos de lo que parecía una enfermedad desconocida en adultos jóvenes,    caracterizada por un pródromo de fiebre, seguido de un rápido    desarrollo de edema pulmonar, derrame pleural, e insuficiencia respiratoria,    asociados a trombocitopenia y leucocitosis y, en casos severos, acidosis láctica,    colapso cardiovascular y muerte.1 Investigadores    del Centro de Control de Enfermedades en Atlanta, Georgia (U.S. Centers for    Disease Control and Prevention - CDC) analizaron muestras de suero obtenidas    de estos pacientes y observaron que presentaban una reacción serológica    positiva contra un grupo de virus conocidos como patógenos humanos, denominados    hantavirus, incluido el prototipo hantavirus, que causa la fiebre hemorrágica    con síndrome renal (FHSR) en Asia. Este hallazgo fue seguido por la detección    de ARN de hantavirus por técnica de transcripción reversa y reacción    de polimerasa en cadena (TT-RPC) en tejidos obtenidos en las autopsias de los    casos fatales y de muestras de células mononucleares de sangre periférica    obtenidas de pacientes durante la fase aguda de la enfermedad,2    así como de roedores (Peromyscus maniculatus) cazados en trampas    puestas en el área geográfica donde ocurría el brote.3    Posteriormente varios laboratorios aislaron un hantavirus hasta entonces desconocido,    al que se denominó virus Sin Nombre, en el roedor conocido como deer    mouse o ratón venado (P. maniculatus)4    y mediante secuenciación del genoma viral se estableció la relación    genética existente entre los virus que infectan a roedores y humanos.5    El síndrome clínico asociado con el virus en América se    denominó inicialmente síndrome pulmonar por hantavirus (SPH).    El roedor P. maniculatus tiene una amplia distribución a lo largo    de casi todo el territorio de Norte América, y el virus Sin Nombre se    ha reconocido como la causa de la mayoría de los 270 casos notificados    en E.U.A. hasta el 12 de septiembre del 2000. 

Poco tiempo después del descubrimiento del virus    Sin Nombre, se notificaron casos de SPH y nuevas especies de hantavirus fueron    descritas a lo largo de todo el continente americano, habiéndose confirmado    casos en Argentina,6-9 Brasil,10    Canadá,11 Chile,8,12,    13 Panamá,14 Paraguay15,16    y Uruguay.11 En estos países se han identificado    nuevas especies de hantavirus; sin embargo, entre los hantavirus identificados    en roedores en América, sólo la mitad se ha asociado a enfermedad    en humanos. El virus Sin Nombre sigue siendo el hantavirus más importante    de Norteamérica, región en la que también se ha notificado    un bajo número de casos causados por el virus Bayou (huésped natural    Oryzomys palustris) o el virus Black Creek Canal (huésped natural    Sigmodon hispidus). En América Central y del Sur el cuadro es    más complejo. El virus Andes (huésped natural Oligoryzomys    longicaudatus) es el principal patógeno en Chile y Argentina, pero    probablemente hay otros hantavirus, incluyendo el virus Oran y el virus Lechiguanas,    que causan enfermedad en la región central y noroeste de Argentina, el    virus Laguna Negra (huésped natural Calomys laucha) un patógeno    reconocido en Paraguay y Bolivia16, 17    y el virus Juquitiba (huésped natural desconocido) en Brasil. La reciente    notificación de 12 casos en Panamá durante 1999 y 200014es    de especial interés ya que sugiere la posibilidad de que aún existan    enfermedades no reconocidas por hantavirus en humanos y otras especies de hantavirus    en regiones tropicales de América Central y América del Sur. El    hantavirus identificado en Panamá se ha denominado virus Choclo y se    determinó que su huésped natural es Oligoryzomys fulvescens.    

 Cada uno de los hantavirus mencionados se asocia a una especie    de roedor específico, en quien el virus causa una infección crónica,    con viremia persistente y asintomática, constituyéndose en el    reservorio natural de la infección. Los trabajos presentados aquí    por C. Pavletic y A. Spotorno et al. nos entregan valiosa información    de las especies de roedores en las que se ha identificado hantavirus en Chile,    sus características biológicas, su distribución geográfica    y la prevalencia de infección en las poblaciones de roedores. Cinco especies    de roedores silvestres de las regiones central y sur de Chile presentaron individuos    con reactividad serológica a hantavirus; en dos de ellos, Olygoryzomys    longicaudatus y Abrothrix longipilis, se logró determinar    la presencia del virus mediante técnicas de biología molecular.    El virus identificado en O. longicaudatus corresponde genéticamente    al virus Andes, que se ha establecido como el principal patógeno para    humanos en la región. Aún queda por definir si la reactividad    serológica observada en otras especies representa un fenómeno    biológico de derrame (infección transitoria de otras especies    a partir del reservorio natural en O. longicaudatus), o corresponde a    verdaderas nuevas especies de hantavirus que han evolucionado para infectar    específicamente a estas especies y cuya patogenicidad es aún desconocida.  

 La identificación de hantavirus, tanto en humanos como    en roedores, y el estudio de sus secuencias genéticas para establecer    sus similitudes y diferencias, han utilizado todas las herramientas modernas    que ofrece la biología y se han caracterizado por su rápido desarrollo    ante una infección emergente.2, 18,    19 Galeno et al nos ofrecen en esta revista una perspectiva de las    bases biológicas de estos métodos y el resultado de su aplicación    durante los brotes ocurridos en diversas regiones de Chile. Se informa aquí    también, en forma preliminar, un hallazgo de gran trascendencia mundial,    cual es la descripción del primer aislamiento de hantavirus a partir    de muestras de un ser humano. Las circunstancias en que se produjo este aislamiento    tienen una importante proyección en la comprensión de la patogenia    de la infección, en cuanto sugieren la existencia de una viremia antes    de que se produzcan la enfermedad y respuesta inmunológica. 

 El hantavirus se transmite al hombre por inhalación    de aerosoles generados a partir de saliva, orina o deposiciones de roedores    infectados. Las circunstancias en que esto puede ocurrir son diversas. Sotomayor    y Aguilera presentan aquí una descripción de las observaciones    epidemiológicas realizadas en Chile por el Departamento de Epidemiología    del Ministerio de Salud, así como una completa revisión del sistema    de vigilancia establecido en el país, como herramienta fundamental para    establecer intervenciones preventivas efectivas. Estudios realizados en Argentina    han generado evidencias epidemiológicas y virológicas de transmisión    persona a persona del virus Andes (20, 21). En Chile no se ha notificado    ningún caso de transmisión nosocomial, ni se han documentado casos    de transmisión persona a persona, aunque este mecanismo ha sido sugerido    en algunos brotes intrafamiliares.13 El hecho de    que en Chile se haya observado que 30% de los casos se producen en grupos familares    (dos o más miembros de una familia afectados), requiere de estudios que    permitan determinar si esto se debe a exposición a una fuente común    de infección o bien, a transmisión persona a persona. Estudios    de seroprevalencia de hantavirus en diversas regiones de América muestran    que entre 1 y 13% de los individuos de las poblaciones estudiadas presentan    anticuerpos contra este virus. Estas observaciones son concordantes con el hallazgo    presentado por Sotomayor y Aguilera de infecciones clínicamente leves    o asintomáticas, indicando que no todas las infecciones evolucionan hacia    SPH. 

 Nuestro conocimiento de la evolución clínica    y la patofisiología de la enfermedad por hantavirus ha progresado significativamente    desde que fue reconocida en 1993.22 Durante la    epidemia de 1993-94 en el Sur-Oeste de E.U.A., investigadores clínicos    de la University of New Mexico describieron la importancia de la depresión    de la función cardíaca y el shock en los casos severos y fatales.23    Estos fenómenos son de importancia en la comprensión de la patogenia    de la enfermedad severa y también tienen utilidad como herramienta de    diagnóstico, ya que la medición del índice cardíaco,    la presión de lecho pulmonar y la resistencia vascular sistémica,    ayudan en la diferenciación del shock séptico del producido por    la infección por hantavirus.23 Consecuentemente,    ante la importancia de la disminución de la función cardíaca    en la patogenia de la evolución severa o la fatal, se prefiere actualmente    denominar la enfermedad como síndrome cardiopulmonar por hantavirus (SCPH).  

 Las características clínicas de la infección    por hantavirus, pueden diferir según la especie de virus que infecta    a un individuo. Los virus presentes en Asia y Europa parecen focalizar el mayor    daño clínico en el riñón y los presentes en América,    en el pulmón y en el corazón. Los trabajos presentados por Navarrete    et al, Castillo et al y Tapia et al, nos permiten establecer las características    clínicas observadas en los individuos infectados en Chile, sugiriendo    que el síndrome clínico observado en esta región tiene    mayor compromiso hemorrágico y renal, asociado al compromiso cardiopulmonar    observado en Norte América. Al mismo tiempo, es importante destacar que    en Chile, en relación a Norte América, se observa que un mayor    porcentaje de los casos afecta a menores de 15 años (15% de los casos).    Soza et al nos ofrecen aquí una valiosa descripción de las características    clínico-epidemiológicas de 6 casos pediátricos en la IX    y X regiones de Chile. 

 Actualmente no se cuenta con una terapia efectiva y probada    contra el SCPH; sin embargo, diversas observaciones recientes indican que existen    intervenciones terapéuticas que merecen considerarse para ser incluidas    en ensayos clínicos controlados. 

 El antiviral ribavirina, administrado en forma endovenosa,    está siendo evaluado desde 1995 en un ensayo clínico controlado    con placebo en E.U.A. y Canadá. El interés por evaluar la ribavirina    se basa no sólo en la demostración de que este antiviral tiene    actividad in vitro contra el virus, sino también en la demostración    de su eficacia. En un estudio prospectivo, doble-ciego, controlado por placebo,    efectuado sobre 242 pacientes en China, con infección confirmada por    el virus que produce fiebre hemorrágica con síndrome renal, se    estableció su eficacia al disminuir la mortalidad y el desarrollo de    insuficiencia renal.24 

 Si bien la evaluación de ribavirina endovenosa en el    SCPH está en curso, existe preocupación de que el estudio no reclute    suficiente número de pacientes para determinar si ella es efectiva; tampoco    ha sido posible incorporar un número significativo de pacientes durante    la fase de pródromo febril, etapa en la que la ribavirina tendría,    teóricamente, la mejor oportunidad de ser efectiva y traducirse en beneficios    para el paciente. La evidencia actualmente disponible sugiere que la fase de    compromiso cardiopulmonar del SCPH podría ser mediada por respuestas    de inmunidad celular y por una "tormenta de citokinas".25    Existe entonces interés, por parte de investigadores de numerosos países,    incluidos Argentina, Canadá, Chile y E.U.A., en diseñar ensayos    clínicos que puedan evaluar terapias con corticosteroides u otras terapias    inmuno-modulatorias en pacientes en fase cardiopulmonar del SCPH. 

 La Unidad de Cuidados Intensivos de University of New Mexico    Health Sciences Center (UNMHSC) ha usado oxigenación con membrana extra    corpórea (extracorporal membrane oxygenation ó ECMO) en 27 pacientes    con SCPH severo, en quienes se esperaba que tendrían una evolución    fatal si no se trataban. De estos 27 pacientes, 11 fallecieron, uno está    aún conectado a ECMO al escribir esta editorial, uno salió recientemente    de ECMO y se espera que sobreviva, y 14 han sido dados de alta del hospital    (M. Crowley, comunicación personal). Estos resultados son prometedores    pero no resulta claro cuán ampliamente puede o debe ser adoptado el uso    de ECMO. Sólo un limitado número de centros en E.U.A. y Canadá    han utilizado ECMO para el SCPH, y pocos, fuera de la University of New Mexico    han tratado más de uno o dos pacientes. Si bien ECMO está disponible    en algunos centros de Santiago, la mayoría de los pacientes con SCPH    son hospitalizados en centros distantes de aquellos que cuentan con experiencia    en ECMO, y el transporte oportuno a Santiago es muy difícil para la mayoría    de estos pacientes. Durante un seminario realizado en Temuco, en Marzo del 2000,    algunos médicos clínicos chilenos sugirieron una evaluación    abierta del uso de contra-pulsación con balón aórtico en    un número limitado de pacientes con shock secundario de SCPH. 

 Investigadores de la University of New Mexico informaron recientemente    que los pacienes con SCPH severo o fatal tenían títulos de anticuerpos    neutralizantes significativamente menores el día de ingreso al hospital    que los títulos observados en aquellos pacientes con enfermedad moderada.26    Se han diseñado estudios, por parte de investigadores del ISP de Chile    y la Pontificia Universidad Católica de Chile, para evaluar si este fenómeno    está también presente en individuos con SCPH causado por el virus    Andes en Chile. Si estos resultados son confirmados en SCPH por virus Andes    en Chile, se podría considerar el inicio de ensayos terapéuticos    con anticuerpos neutralizantes. 

 La prevención y el manejo ambiental representan actualmente    la mejor herramienta de salud pública contra la infección por    hantavirus. Pavletic presenta en este número una detallada revisión    de las intervenciones efectivas para lograr este objetivo, a la luz de los antecedentes    disponibles de la epidemiología de la infección en Chile. 

 La información entregada en este número de la    Revista Chilena de Infectología, mediante trabajos originales, representa    un modelo de trabajo científico frente a la emergencia de una infección    en una región, caracterizado por un estudio colaborativo entre profesionales    de diversas disciplinas, por el esfuerzo de transformar en experiencia y una    instancia formativa el trabajo epidemiológico, clínico y de laboratorio,    y por la solidez de los resultados que generan conocimientos relevantes a nivel    mundial. 

1  Department of Internal Medicine,    University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA;         2  Departamento de Pediatría y Centro de    Investigaciones Médicas, Facultad de Medicina, Pontificia Universidad    Católica de Chile        Este artículo contó con el apoyo de un Proyecto de U.S. Public    Health Service, número AI45452 and TW01133 

BIBLIOGRAFIA 

 1.- Duchin J S, Koster F, Peters C J et al.    Hantavirus pulmonary syndrome: a clinical description of 17 patients with a    newly recognized disease. N Engl J Med 1994; 330 (14): 949-55.         [ Links ] 2.- Ksiazec T G, Peters C J, Rollin P E et    al. Identification of a new north american hantavirus that causes acute pulmonary    insufficiency. Am J Trop Med Hyg 1995; 52: 117-23.         [ Links ] 3.- Childs J E, Ksiazek T, Spiropoulou C F    et al. Serologic and genetic identification of Peromyscus maniculatus    as the primary rodent reservoir for a new hantavirus in the southwestern United    States. J Infect Dis 1994; 169: 1271-80.         [ Links ] 4.- Young J, Mills J, Enria D, Dolan N, Khan    A, Ksiazek T. New World hantaviruses. Brit Med Bull 1998; 54: 569-73.         [ Links ] 5.- Hjelle B, Torrez-Martinez Norah, Koster    F T et al. Epidemiologic linkage of rodent and human hantavirus genomic sequences    in case investigations of Hantavirus Pulmonary Syndrome. J Infect Dis 1996;    173: 781-86.         [ Links ] 6.- Levis S C, Briggiler A M, Cacass M. Emergence    of hantavirus pulmonary syndrome in Argentina (abstr.) Am. J Trop Med Hyg 1995;    53 (suppl): 441.         [ Links ] 7.- Lopez N, Padula P, Rossi C et al. Genetic    identification of a new hantavirus causing severe pulmonary syndrome in Argentina.    Virology 1996; 220: 223-6.         [ Links ] 8.- Lopez N, Padula P, Rossi C et al. Genetic    characterization and phylogeny of Andes virus and variants from Argentina and    Chile. Virus Res 1997; 50: 77-84.         [ Links ] 9.- Levis S, Morzunov S, Rowe J et al. Genetic    diversity and epidemiology of hantavirus in Argentina. J Infect Dis 1998; 177:    529-38.         [ Links ]10.- Zaparolli M A, Iversson L B, Rosa M D    et al. Investigation on case contacts of human disease caused by hantavirus    in Juquitiba, State of Sao Paulo, Brazil. (abstr.) Am J Trop Med Hyg 1995; 53    (suppl): 439-         [ Links ]11.- Doyle T, Bryan R, Peters C J. Viral Hemorrhagic    Fevers and Hantavirus Infections in the Americas. Infect Dis Clin N A 1998;    12: 95-110.         [ Links ]12.- Centers for Diseases Control and Prevention    Hantavirus Pulmonary Syndrome-Chile 1997. MMWR 1997; 46: 949-51.         [ Links ]13.- Toro J, Vega J, Khan A et al. An outbreak    of hantavirus pulmonary syndrome, Chile 1997. Emerg Infect Dis 1998; 4: 667-702.          [ Links ]14.- Centers for Diseases Control and Prevention.    Hantavirus Pulmonary Syndrome - Panama 1999-2000. MMWR 2000; 49 (10): 205-7.          [ Links ]15.- Williams R J, Bryan R T, Mills J N. An    outbreak of Hantavirus Pulmonary Syndrome in Western Paraguay. Am J Trop Med    Hyg 1997; 57: 274-82.         [ Links ]16.- Johnson A M, Bowen M D, Ksiazek T G et    al. Laguna Negra virus associated with HPS in Western Paraguay and Bolivia.    Virology 1997; 238: 115-27.         [ Links ]17.- Espinoza R, Vial P, Noriega L M et al.    Hantavirus Pulmonary Syndrome in a Chilean patient with recent travel to Bolivia.    Emerg Infect Dis 1998; 4: 93-5.         [ Links ]18.- HJelle B, Jenison S, Torrez-Martinez    N et al. Rapid and specific detection of Sin Nombre virus antibodies in patients    with Hantavirus Pulmonary Syndrome by a strip immunoblot assay suitable for    field diagnosis. J Clin Microbiol 1997; 35: 600-8.         [ Links ]19.- Elgh F, Lundkvist A, Alexeyev A et al. Serological    diagnosis of Hantavirus infections by an enzyme-linked immunosorbent assay based    on detection of immunoglobulin G and M responses to recombinant nucleocapsid    proteins of five viral serotypes. J Clin Microbiol 1997; 35:1122-30.         [ Links ]20.- Wells R, Sosa S, Yadon Z et al. An unusual    Hantavirus outbreak in Southern Argentina: person to person transmission?. Emerg    Infect Dis 1997; 3: 171-4.         [ Links ]21.- Padula P J, Edelstein A, Miguel D L et    al. Hantavirus Pulmonary Syndrome outbreak in Argentina: Molecular evidence    for person to person transmission of Andes virus. Virology; 1998; 241: 323-30.          [ Links ]22.- Zaki S R, Greer P, Coffield L et al.    Hantavirus Pulmonary Syndrome. Pathogenesis of an emerging infectious diseases.    Am J Pathol; 1995; 146: 552-79.         [ Links ]23.- Hallin G, Simpson S, Crowell R et al.    Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med    1996; 24 (2): 252-8.         [ Links ]24.- Huggins J W, Hsiang C M, Cosgriff T M    et al. Prospective, double-blind, concurrent, placebo-controled clinical trial    of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J    Infect Dis 1991; 164: 1119-27.         [ Links ]25. Mertz G J, Hjelle B L, Williams T M, Koster    F T. Host responses in the Hantavirus Cardiopulmonary Syndrome. In: Saluzzo    JF, Dodet B, eds. Factors in the Emergence and Control of Rodent-Borne Viral    Diseases. Elsevier, Paris 1999; pp 133-7.         [ Links ]26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 

 2.- Ksiazec T G, Peters C J, Rollin P E et    al. Identification of a new north american hantavirus that causes acute pulmonary    insufficiency. Am J Trop Med Hyg 1995; 52: 117-23.         [ Links ] 3.- Childs J E, Ksiazek T, Spiropoulou C F    et al. Serologic and genetic identification of Peromyscus maniculatus    as the primary rodent reservoir for a new hantavirus in the southwestern United    States. J Infect Dis 1994; 169: 1271-80.         [ Links ] 4.- Young J, Mills J, Enria D, Dolan N, Khan    A, Ksiazek T. New World hantaviruses. Brit Med Bull 1998; 54: 569-73.         [ Links ] 5.- Hjelle B, Torrez-Martinez Norah, Koster    F T et al. Epidemiologic linkage of rodent and human hantavirus genomic sequences    in case investigations of Hantavirus Pulmonary Syndrome. J Infect Dis 1996;    173: 781-86.         [ Links ] 6.- Levis S C, Briggiler A M, Cacass M. Emergence    of hantavirus pulmonary syndrome in Argentina (abstr.) Am. J Trop Med Hyg 1995;    53 (suppl): 441.         [ Links ] 7.- Lopez N, Padula P, Rossi C et al. Genetic    identification of a new hantavirus causing severe pulmonary syndrome in Argentina.    Virology 1996; 220: 223-6.         [ Links ] 8.- Lopez N, Padula P, Rossi C et al. Genetic    characterization and phylogeny of Andes virus and variants from Argentina and    Chile. Virus Res 1997; 50: 77-84.         [ Links ] 9.- Levis S, Morzunov S, Rowe J et al. Genetic    diversity and epidemiology of hantavirus in Argentina. J Infect Dis 1998; 177:    529-38.         [ Links ]10.- Zaparolli M A, Iversson L B, Rosa M D    et al. Investigation on case contacts of human disease caused by hantavirus    in Juquitiba, State of Sao Paulo, Brazil. (abstr.) Am J Trop Med Hyg 1995; 53    (suppl): 439-         [ Links ]11.- Doyle T, Bryan R, Peters C J. Viral Hemorrhagic    Fevers and Hantavirus Infections in the Americas. Infect Dis Clin N A 1998;    12: 95-110.         [ Links ]12.- Centers for Diseases Control and Prevention    Hantavirus Pulmonary Syndrome-Chile 1997. MMWR 1997; 46: 949-51.         [ Links ]13.- Toro J, Vega J, Khan A et al. An outbreak    of hantavirus pulmonary syndrome, Chile 1997. Emerg Infect Dis 1998; 4: 667-702.          [ Links ]14.- Centers for Diseases Control and Prevention.    Hantavirus Pulmonary Syndrome - Panama 1999-2000. MMWR 2000; 49 (10): 205-7.          [ Links ]15.- Williams R J, Bryan R T, Mills J N. An    outbreak of Hantavirus Pulmonary Syndrome in Western Paraguay. Am J Trop Med    Hyg 1997; 57: 274-82.         [ Links ]16.- Johnson A M, Bowen M D, Ksiazek T G et    al. Laguna Negra virus associated with HPS in Western Paraguay and Bolivia.    Virology 1997; 238: 115-27.         [ Links ]17.- Espinoza R, Vial P, Noriega L M et al.    Hantavirus Pulmonary Syndrome in a Chilean patient with recent travel to Bolivia.    Emerg Infect Dis 1998; 4: 93-5.         [ Links ]18.- HJelle B, Jenison S, Torrez-Martinez    N et al. Rapid and specific detection of Sin Nombre virus antibodies in patients    with Hantavirus Pulmonary Syndrome by a strip immunoblot assay suitable for    field diagnosis. J Clin Microbiol 1997; 35: 600-8.         [ Links ]19.- Elgh F, Lundkvist A, Alexeyev A et al. Serological    diagnosis of Hantavirus infections by an enzyme-linked immunosorbent assay based    on detection of immunoglobulin G and M responses to recombinant nucleocapsid    proteins of five viral serotypes. J Clin Microbiol 1997; 35:1122-30.         [ Links ]20.- Wells R, Sosa S, Yadon Z et al. An unusual    Hantavirus outbreak in Southern Argentina: person to person transmission?. Emerg    Infect Dis 1997; 3: 171-4.         [ Links ]21.- Padula P J, Edelstein A, Miguel D L et    al. Hantavirus Pulmonary Syndrome outbreak in Argentina: Molecular evidence    for person to person transmission of Andes virus. Virology; 1998; 241: 323-30.          [ Links ]22.- Zaki S R, Greer P, Coffield L et al.    Hantavirus Pulmonary Syndrome. Pathogenesis of an emerging infectious diseases.    Am J Pathol; 1995; 146: 552-79.         [ Links ]23.- Hallin G, Simpson S, Crowell R et al.    Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med    1996; 24 (2): 252-8.         [ Links ]24.- Huggins J W, Hsiang C M, Cosgriff T M    et al. Prospective, double-blind, concurrent, placebo-controled clinical trial    of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J    Infect Dis 1991; 164: 1119-27.         [ Links ]25. Mertz G J, Hjelle B L, Williams T M, Koster    F T. Host responses in the Hantavirus Cardiopulmonary Syndrome. In: Saluzzo    JF, Dodet B, eds. Factors in the Emergence and Control of Rodent-Borne Viral    Diseases. Elsevier, Paris 1999; pp 133-7.         [ Links ]26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 

 3.- Childs J E, Ksiazek T, Spiropoulou C F    et al. Serologic and genetic identification of Peromyscus maniculatus    as the primary rodent reservoir for a new hantavirus in the southwestern United    States. J Infect Dis 1994; 169: 1271-80.         [ Links ] 4.- Young J, Mills J, Enria D, Dolan N, Khan    A, Ksiazek T. New World hantaviruses. Brit Med Bull 1998; 54: 569-73.         [ Links ] 5.- Hjelle B, Torrez-Martinez Norah, Koster    F T et al. Epidemiologic linkage of rodent and human hantavirus genomic sequences    in case investigations of Hantavirus Pulmonary Syndrome. J Infect Dis 1996;    173: 781-86.         [ Links ] 6.- Levis S C, Briggiler A M, Cacass M. Emergence    of hantavirus pulmonary syndrome in Argentina (abstr.) Am. J Trop Med Hyg 1995;    53 (suppl): 441.         [ Links ] 7.- Lopez N, Padula P, Rossi C et al. Genetic    identification of a new hantavirus causing severe pulmonary syndrome in Argentina.    Virology 1996; 220: 223-6.         [ Links ] 8.- Lopez N, Padula P, Rossi C et al. Genetic    characterization and phylogeny of Andes virus and variants from Argentina and    Chile. Virus Res 1997; 50: 77-84.         [ Links ] 9.- Levis S, Morzunov S, Rowe J et al. Genetic    diversity and epidemiology of hantavirus in Argentina. J Infect Dis 1998; 177:    529-38.         [ Links ]10.- Zaparolli M A, Iversson L B, Rosa M D    et al. Investigation on case contacts of human disease caused by hantavirus    in Juquitiba, State of Sao Paulo, Brazil. (abstr.) Am J Trop Med Hyg 1995; 53    (suppl): 439-         [ Links ]11.- Doyle T, Bryan R, Peters C J. Viral Hemorrhagic    Fevers and Hantavirus Infections in the Americas. Infect Dis Clin N A 1998;    12: 95-110.         [ Links ]12.- Centers for Diseases Control and Prevention    Hantavirus Pulmonary Syndrome-Chile 1997. MMWR 1997; 46: 949-51.         [ Links ]13.- Toro J, Vega J, Khan A et al. An outbreak    of hantavirus pulmonary syndrome, Chile 1997. Emerg Infect Dis 1998; 4: 667-702.          [ Links ]14.- Centers for Diseases Control and Prevention.    Hantavirus Pulmonary Syndrome - Panama 1999-2000. MMWR 2000; 49 (10): 205-7.          [ Links ]15.- Williams R J, Bryan R T, Mills J N. An    outbreak of Hantavirus Pulmonary Syndrome in Western Paraguay. Am J Trop Med    Hyg 1997; 57: 274-82.         [ Links ]16.- Johnson A M, Bowen M D, Ksiazek T G et    al. Laguna Negra virus associated with HPS in Western Paraguay and Bolivia.    Virology 1997; 238: 115-27.         [ Links ]17.- Espinoza R, Vial P, Noriega L M et al.    Hantavirus Pulmonary Syndrome in a Chilean patient with recent travel to Bolivia.    Emerg Infect Dis 1998; 4: 93-5.         [ Links ]18.- HJelle B, Jenison S, Torrez-Martinez    N et al. Rapid and specific detection of Sin Nombre virus antibodies in patients    with Hantavirus Pulmonary Syndrome by a strip immunoblot assay suitable for    field diagnosis. J Clin Microbiol 1997; 35: 600-8.         [ Links ]19.- Elgh F, Lundkvist A, Alexeyev A et al. Serological    diagnosis of Hantavirus infections by an enzyme-linked immunosorbent assay based    on detection of immunoglobulin G and M responses to recombinant nucleocapsid    proteins of five viral serotypes. J Clin Microbiol 1997; 35:1122-30.         [ Links ]20.- Wells R, Sosa S, Yadon Z et al. An unusual    Hantavirus outbreak in Southern Argentina: person to person transmission?. Emerg    Infect Dis 1997; 3: 171-4.         [ Links ]21.- Padula P J, Edelstein A, Miguel D L et    al. Hantavirus Pulmonary Syndrome outbreak in Argentina: Molecular evidence    for person to person transmission of Andes virus. Virology; 1998; 241: 323-30.          [ Links ]22.- Zaki S R, Greer P, Coffield L et al.    Hantavirus Pulmonary Syndrome. Pathogenesis of an emerging infectious diseases.    Am J Pathol; 1995; 146: 552-79.         [ Links ]23.- Hallin G, Simpson S, Crowell R et al.    Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med    1996; 24 (2): 252-8.         [ Links ]24.- Huggins J W, Hsiang C M, Cosgriff T M    et al. Prospective, double-blind, concurrent, placebo-controled clinical trial    of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J    Infect Dis 1991; 164: 1119-27.         [ Links ]25. Mertz G J, Hjelle B L, Williams T M, Koster    F T. Host responses in the Hantavirus Cardiopulmonary Syndrome. In: Saluzzo    JF, Dodet B, eds. Factors in the Emergence and Control of Rodent-Borne Viral    Diseases. Elsevier, Paris 1999; pp 133-7.         [ Links ]26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 

 4.- Young J, Mills J, Enria D, Dolan N, Khan    A, Ksiazek T. New World hantaviruses. Brit Med Bull 1998; 54: 569-73.         [ Links ] 5.- Hjelle B, Torrez-Martinez Norah, Koster    F T et al. Epidemiologic linkage of rodent and human hantavirus genomic sequences    in case investigations of Hantavirus Pulmonary Syndrome. J Infect Dis 1996;    173: 781-86.         [ Links ] 6.- Levis S C, Briggiler A M, Cacass M. Emergence    of hantavirus pulmonary syndrome in Argentina (abstr.) Am. J Trop Med Hyg 1995;    53 (suppl): 441.         [ Links ] 7.- Lopez N, Padula P, Rossi C et al. Genetic    identification of a new hantavirus causing severe pulmonary syndrome in Argentina.    Virology 1996; 220: 223-6.         [ Links ] 8.- Lopez N, Padula P, Rossi C et al. Genetic    characterization and phylogeny of Andes virus and variants from Argentina and    Chile. Virus Res 1997; 50: 77-84.         [ Links ] 9.- Levis S, Morzunov S, Rowe J et al. Genetic    diversity and epidemiology of hantavirus in Argentina. J Infect Dis 1998; 177:    529-38.         [ Links ]10.- Zaparolli M A, Iversson L B, Rosa M D    et al. Investigation on case contacts of human disease caused by hantavirus    in Juquitiba, State of Sao Paulo, Brazil. (abstr.) Am J Trop Med Hyg 1995; 53    (suppl): 439-         [ Links ]11.- Doyle T, Bryan R, Peters C J. Viral Hemorrhagic    Fevers and Hantavirus Infections in the Americas. Infect Dis Clin N A 1998;    12: 95-110.         [ Links ]12.- Centers for Diseases Control and Prevention    Hantavirus Pulmonary Syndrome-Chile 1997. MMWR 1997; 46: 949-51.         [ Links ]13.- Toro J, Vega J, Khan A et al. An outbreak    of hantavirus pulmonary syndrome, Chile 1997. Emerg Infect Dis 1998; 4: 667-702.          [ Links ]14.- Centers for Diseases Control and Prevention.    Hantavirus Pulmonary Syndrome - Panama 1999-2000. MMWR 2000; 49 (10): 205-7.          [ Links ]15.- Williams R J, Bryan R T, Mills J N. An    outbreak of Hantavirus Pulmonary Syndrome in Western Paraguay. Am J Trop Med    Hyg 1997; 57: 274-82.         [ Links ]16.- Johnson A M, Bowen M D, Ksiazek T G et    al. Laguna Negra virus associated with HPS in Western Paraguay and Bolivia.    Virology 1997; 238: 115-27.         [ Links ]17.- Espinoza R, Vial P, Noriega L M et al.    Hantavirus Pulmonary Syndrome in a Chilean patient with recent travel to Bolivia.    Emerg Infect Dis 1998; 4: 93-5.         [ Links ]18.- HJelle B, Jenison S, Torrez-Martinez    N et al. Rapid and specific detection of Sin Nombre virus antibodies in patients    with Hantavirus Pulmonary Syndrome by a strip immunoblot assay suitable for    field diagnosis. J Clin Microbiol 1997; 35: 600-8.         [ Links ]19.- Elgh F, Lundkvist A, Alexeyev A et al. Serological    diagnosis of Hantavirus infections by an enzyme-linked immunosorbent assay based    on detection of immunoglobulin G and M responses to recombinant nucleocapsid    proteins of five viral serotypes. J Clin Microbiol 1997; 35:1122-30.         [ Links ]20.- Wells R, Sosa S, Yadon Z et al. An unusual    Hantavirus outbreak in Southern Argentina: person to person transmission?. Emerg    Infect Dis 1997; 3: 171-4.         [ Links ]21.- Padula P J, Edelstein A, Miguel D L et    al. Hantavirus Pulmonary Syndrome outbreak in Argentina: Molecular evidence    for person to person transmission of Andes virus. Virology; 1998; 241: 323-30.          [ Links ]22.- Zaki S R, Greer P, Coffield L et al.    Hantavirus Pulmonary Syndrome. Pathogenesis of an emerging infectious diseases.    Am J Pathol; 1995; 146: 552-79.         [ Links ]23.- Hallin G, Simpson S, Crowell R et al.    Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med    1996; 24 (2): 252-8.         [ Links ]24.- Huggins J W, Hsiang C M, Cosgriff T M    et al. Prospective, double-blind, concurrent, placebo-controled clinical trial    of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J    Infect Dis 1991; 164: 1119-27.         [ Links ]25. Mertz G J, Hjelle B L, Williams T M, Koster    F T. Host responses in the Hantavirus Cardiopulmonary Syndrome. In: Saluzzo    JF, Dodet B, eds. Factors in the Emergence and Control of Rodent-Borne Viral    Diseases. Elsevier, Paris 1999; pp 133-7.         [ Links ]26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 

 5.- Hjelle B, Torrez-Martinez Norah, Koster    F T et al. Epidemiologic linkage of rodent and human hantavirus genomic sequences    in case investigations of Hantavirus Pulmonary Syndrome. J Infect Dis 1996;    173: 781-86.         [ Links ] 6.- Levis S C, Briggiler A M, Cacass M. Emergence    of hantavirus pulmonary syndrome in Argentina (abstr.) Am. J Trop Med Hyg 1995;    53 (suppl): 441.         [ Links ] 7.- Lopez N, Padula P, Rossi C et al. Genetic    identification of a new hantavirus causing severe pulmonary syndrome in Argentina.    Virology 1996; 220: 223-6.         [ Links ] 8.- Lopez N, Padula P, Rossi C et al. Genetic    characterization and phylogeny of Andes virus and variants from Argentina and    Chile. Virus Res 1997; 50: 77-84.         [ Links ] 9.- Levis S, Morzunov S, Rowe J et al. Genetic    diversity and epidemiology of hantavirus in Argentina. J Infect Dis 1998; 177:    529-38.         [ Links ]10.- Zaparolli M A, Iversson L B, Rosa M D    et al. Investigation on case contacts of human disease caused by hantavirus    in Juquitiba, State of Sao Paulo, Brazil. (abstr.) Am J Trop Med Hyg 1995; 53    (suppl): 439-         [ Links ]11.- Doyle T, Bryan R, Peters C J. Viral Hemorrhagic    Fevers and Hantavirus Infections in the Americas. Infect Dis Clin N A 1998;    12: 95-110.         [ Links ]12.- Centers for Diseases Control and Prevention    Hantavirus Pulmonary Syndrome-Chile 1997. MMWR 1997; 46: 949-51.         [ Links ]13.- Toro J, Vega J, Khan A et al. An outbreak    of hantavirus pulmonary syndrome, Chile 1997. Emerg Infect Dis 1998; 4: 667-702.          [ Links ]14.- Centers for Diseases Control and Prevention.    Hantavirus Pulmonary Syndrome - Panama 1999-2000. MMWR 2000; 49 (10): 205-7.          [ Links ]15.- Williams R J, Bryan R T, Mills J N. An    outbreak of Hantavirus Pulmonary Syndrome in Western Paraguay. Am J Trop Med    Hyg 1997; 57: 274-82.         [ Links ]16.- Johnson A M, Bowen M D, Ksiazek T G et    al. Laguna Negra virus associated with HPS in Western Paraguay and Bolivia.    Virology 1997; 238: 115-27.         [ Links ]17.- Espinoza R, Vial P, Noriega L M et al.    Hantavirus Pulmonary Syndrome in a Chilean patient with recent travel to Bolivia.    Emerg Infect Dis 1998; 4: 93-5.         [ Links ]18.- HJelle B, Jenison S, Torrez-Martinez    N et al. Rapid and specific detection of Sin Nombre virus antibodies in patients    with Hantavirus Pulmonary Syndrome by a strip immunoblot assay suitable for    field diagnosis. J Clin Microbiol 1997; 35: 600-8.         [ Links ]19.- Elgh F, Lundkvist A, Alexeyev A et al. Serological    diagnosis of Hantavirus infections by an enzyme-linked immunosorbent assay based    on detection of immunoglobulin G and M responses to recombinant nucleocapsid    proteins of five viral serotypes. J Clin Microbiol 1997; 35:1122-30.         [ Links ]20.- Wells R, Sosa S, Yadon Z et al. An unusual    Hantavirus outbreak in Southern Argentina: person to person transmission?. Emerg    Infect Dis 1997; 3: 171-4.         [ Links ]21.- Padula P J, Edelstein A, Miguel D L et    al. Hantavirus Pulmonary Syndrome outbreak in Argentina: Molecular evidence    for person to person transmission of Andes virus. Virology; 1998; 241: 323-30.          [ Links ]22.- Zaki S R, Greer P, Coffield L et al.    Hantavirus Pulmonary Syndrome. Pathogenesis of an emerging infectious diseases.    Am J Pathol; 1995; 146: 552-79.         [ Links ]23.- Hallin G, Simpson S, Crowell R et al.    Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med    1996; 24 (2): 252-8.         [ Links ]24.- Huggins J W, Hsiang C M, Cosgriff T M    et al. Prospective, double-blind, concurrent, placebo-controled clinical trial    of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J    Infect Dis 1991; 164: 1119-27.         [ Links ]25. Mertz G J, Hjelle B L, Williams T M, Koster    F T. Host responses in the Hantavirus Cardiopulmonary Syndrome. In: Saluzzo    JF, Dodet B, eds. Factors in the Emergence and Control of Rodent-Borne Viral    Diseases. Elsevier, Paris 1999; pp 133-7.         [ Links ]26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 

 6.- Levis S C, Briggiler A M, Cacass M. Emergence    of hantavirus pulmonary syndrome in Argentina (abstr.) Am. J Trop Med Hyg 1995;    53 (suppl): 441.         [ Links ] 7.- Lopez N, Padula P, Rossi C et al. Genetic    identification of a new hantavirus causing severe pulmonary syndrome in Argentina.    Virology 1996; 220: 223-6.         [ Links ] 8.- Lopez N, Padula P, Rossi C et al. Genetic    characterization and phylogeny of Andes virus and variants from Argentina and    Chile. Virus Res 1997; 50: 77-84.         [ Links ] 9.- Levis S, Morzunov S, Rowe J et al. Genetic    diversity and epidemiology of hantavirus in Argentina. J Infect Dis 1998; 177:    529-38.         [ Links ]10.- Zaparolli M A, Iversson L B, Rosa M D    et al. Investigation on case contacts of human disease caused by hantavirus    in Juquitiba, State of Sao Paulo, Brazil. (abstr.) Am J Trop Med Hyg 1995; 53    (suppl): 439-         [ Links ]11.- Doyle T, Bryan R, Peters C J. Viral Hemorrhagic    Fevers and Hantavirus Infections in the Americas. Infect Dis Clin N A 1998;    12: 95-110.         [ Links ]12.- Centers for Diseases Control and Prevention    Hantavirus Pulmonary Syndrome-Chile 1997. MMWR 1997; 46: 949-51.         [ Links ]13.- Toro J, Vega J, Khan A et al. An outbreak    of hantavirus pulmonary syndrome, Chile 1997. Emerg Infect Dis 1998; 4: 667-702.          [ Links ]14.- Centers for Diseases Control and Prevention.    Hantavirus Pulmonary Syndrome - Panama 1999-2000. MMWR 2000; 49 (10): 205-7.          [ Links ]15.- Williams R J, Bryan R T, Mills J N. An    outbreak of Hantavirus Pulmonary Syndrome in Western Paraguay. Am J Trop Med    Hyg 1997; 57: 274-82.         [ Links ]16.- Johnson A M, Bowen M D, Ksiazek T G et    al. Laguna Negra virus associated with HPS in Western Paraguay and Bolivia.    Virology 1997; 238: 115-27.         [ Links ]17.- Espinoza R, Vial P, Noriega L M et al.    Hantavirus Pulmonary Syndrome in a Chilean patient with recent travel to Bolivia.    Emerg Infect Dis 1998; 4: 93-5.         [ Links ]18.- HJelle B, Jenison S, Torrez-Martinez    N et al. Rapid and specific detection of Sin Nombre virus antibodies in patients    with Hantavirus Pulmonary Syndrome by a strip immunoblot assay suitable for    field diagnosis. J Clin Microbiol 1997; 35: 600-8.         [ Links ]19.- Elgh F, Lundkvist A, Alexeyev A et al. Serological    diagnosis of Hantavirus infections by an enzyme-linked immunosorbent assay based    on detection of immunoglobulin G and M responses to recombinant nucleocapsid    proteins of five viral serotypes. J Clin Microbiol 1997; 35:1122-30.         [ Links ]20.- Wells R, Sosa S, Yadon Z et al. An unusual    Hantavirus outbreak in Southern Argentina: person to person transmission?. Emerg    Infect Dis 1997; 3: 171-4.         [ Links ]21.- Padula P J, Edelstein A, Miguel D L et    al. Hantavirus Pulmonary Syndrome outbreak in Argentina: Molecular evidence    for person to person transmission of Andes virus. Virology; 1998; 241: 323-30.          [ Links ]22.- Zaki S R, Greer P, Coffield L et al.    Hantavirus Pulmonary Syndrome. Pathogenesis of an emerging infectious diseases.    Am J Pathol; 1995; 146: 552-79.         [ Links ]23.- Hallin G, Simpson S, Crowell R et al.    Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med    1996; 24 (2): 252-8.         [ Links ]24.- Huggins J W, Hsiang C M, Cosgriff T M    et al. Prospective, double-blind, concurrent, placebo-controled clinical trial    of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J    Infect Dis 1991; 164: 1119-27.         [ Links ]25. Mertz G J, Hjelle B L, Williams T M, Koster    F T. Host responses in the Hantavirus Cardiopulmonary Syndrome. In: Saluzzo    JF, Dodet B, eds. Factors in the Emergence and Control of Rodent-Borne Viral    Diseases. Elsevier, Paris 1999; pp 133-7.         [ Links ]26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 

 7.- Lopez N, Padula P, Rossi C et al. Genetic    identification of a new hantavirus causing severe pulmonary syndrome in Argentina.    Virology 1996; 220: 223-6.         [ Links ] 8.- Lopez N, Padula P, Rossi C et al. Genetic    characterization and phylogeny of Andes virus and variants from Argentina and    Chile. Virus Res 1997; 50: 77-84.         [ Links ] 9.- Levis S, Morzunov S, Rowe J et al. Genetic    diversity and epidemiology of hantavirus in Argentina. J Infect Dis 1998; 177:    529-38.         [ Links ]10.- Zaparolli M A, Iversson L B, Rosa M D    et al. Investigation on case contacts of human disease caused by hantavirus    in Juquitiba, State of Sao Paulo, Brazil. (abstr.) Am J Trop Med Hyg 1995; 53    (suppl): 439-         [ Links ]11.- Doyle T, Bryan R, Peters C J. Viral Hemorrhagic    Fevers and Hantavirus Infections in the Americas. Infect Dis Clin N A 1998;    12: 95-110.         [ Links ]12.- Centers for Diseases Control and Prevention    Hantavirus Pulmonary Syndrome-Chile 1997. MMWR 1997; 46: 949-51.         [ Links ]13.- Toro J, Vega J, Khan A et al. An outbreak    of hantavirus pulmonary syndrome, Chile 1997. Emerg Infect Dis 1998; 4: 667-702.          [ Links ]14.- Centers for Diseases Control and Prevention.    Hantavirus Pulmonary Syndrome - Panama 1999-2000. MMWR 2000; 49 (10): 205-7.          [ Links ]15.- Williams R J, Bryan R T, Mills J N. An    outbreak of Hantavirus Pulmonary Syndrome in Western Paraguay. Am J Trop Med    Hyg 1997; 57: 274-82.         [ Links ]16.- Johnson A M, Bowen M D, Ksiazek T G et    al. Laguna Negra virus associated with HPS in Western Paraguay and Bolivia.    Virology 1997; 238: 115-27.         [ Links ]17.- Espinoza R, Vial P, Noriega L M et al.    Hantavirus Pulmonary Syndrome in a Chilean patient with recent travel to Bolivia.    Emerg Infect Dis 1998; 4: 93-5.         [ Links ]18.- HJelle B, Jenison S, Torrez-Martinez    N et al. Rapid and specific detection of Sin Nombre virus antibodies in patients    with Hantavirus Pulmonary Syndrome by a strip immunoblot assay suitable for    field diagnosis. J Clin Microbiol 1997; 35: 600-8.         [ Links ]19.- Elgh F, Lundkvist A, Alexeyev A et al. Serological    diagnosis of Hantavirus infections by an enzyme-linked immunosorbent assay based    on detection of immunoglobulin G and M responses to recombinant nucleocapsid    proteins of five viral serotypes. J Clin Microbiol 1997; 35:1122-30.         [ Links ]20.- Wells R, Sosa S, Yadon Z et al. An unusual    Hantavirus outbreak in Southern Argentina: person to person transmission?. Emerg    Infect Dis 1997; 3: 171-4.         [ Links ]21.- Padula P J, Edelstein A, Miguel D L et    al. Hantavirus Pulmonary Syndrome outbreak in Argentina: Molecular evidence    for person to person transmission of Andes virus. Virology; 1998; 241: 323-30.          [ Links ]22.- Zaki S R, Greer P, Coffield L et al.    Hantavirus Pulmonary Syndrome. Pathogenesis of an emerging infectious diseases.    Am J Pathol; 1995; 146: 552-79.         [ Links ]23.- Hallin G, Simpson S, Crowell R et al.    Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med    1996; 24 (2): 252-8.         [ Links ]24.- Huggins J W, Hsiang C M, Cosgriff T M    et al. Prospective, double-blind, concurrent, placebo-controled clinical trial    of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J    Infect Dis 1991; 164: 1119-27.         [ Links ]25. Mertz G J, Hjelle B L, Williams T M, Koster    F T. Host responses in the Hantavirus Cardiopulmonary Syndrome. In: Saluzzo    JF, Dodet B, eds. Factors in the Emergence and Control of Rodent-Borne Viral    Diseases. Elsevier, Paris 1999; pp 133-7.         [ Links ]26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 

 8.- Lopez N, Padula P, Rossi C et al. Genetic    characterization and phylogeny of Andes virus and variants from Argentina and    Chile. Virus Res 1997; 50: 77-84.         [ Links ] 9.- Levis S, Morzunov S, Rowe J et al. Genetic    diversity and epidemiology of hantavirus in Argentina. J Infect Dis 1998; 177:    529-38.         [ Links ]10.- Zaparolli M A, Iversson L B, Rosa M D    et al. Investigation on case contacts of human disease caused by hantavirus    in Juquitiba, State of Sao Paulo, Brazil. (abstr.) Am J Trop Med Hyg 1995; 53    (suppl): 439-         [ Links ]11.- Doyle T, Bryan R, Peters C J. Viral Hemorrhagic    Fevers and Hantavirus Infections in the Americas. Infect Dis Clin N A 1998;    12: 95-110.         [ Links ]12.- Centers for Diseases Control and Prevention    Hantavirus Pulmonary Syndrome-Chile 1997. MMWR 1997; 46: 949-51.         [ Links ]13.- Toro J, Vega J, Khan A et al. An outbreak    of hantavirus pulmonary syndrome, Chile 1997. Emerg Infect Dis 1998; 4: 667-702.          [ Links ]14.- Centers for Diseases Control and Prevention.    Hantavirus Pulmonary Syndrome - Panama 1999-2000. MMWR 2000; 49 (10): 205-7.          [ Links ]15.- Williams R J, Bryan R T, Mills J N. An    outbreak of Hantavirus Pulmonary Syndrome in Western Paraguay. Am J Trop Med    Hyg 1997; 57: 274-82.         [ Links ]16.- Johnson A M, Bowen M D, Ksiazek T G et    al. Laguna Negra virus associated with HPS in Western Paraguay and Bolivia.    Virology 1997; 238: 115-27.         [ Links ]17.- Espinoza R, Vial P, Noriega L M et al.    Hantavirus Pulmonary Syndrome in a Chilean patient with recent travel to Bolivia.    Emerg Infect Dis 1998; 4: 93-5.         [ Links ]18.- HJelle B, Jenison S, Torrez-Martinez    N et al. Rapid and specific detection of Sin Nombre virus antibodies in patients    with Hantavirus Pulmonary Syndrome by a strip immunoblot assay suitable for    field diagnosis. J Clin Microbiol 1997; 35: 600-8.         [ Links ]19.- Elgh F, Lundkvist A, Alexeyev A et al. Serological    diagnosis of Hantavirus infections by an enzyme-linked immunosorbent assay based    on detection of immunoglobulin G and M responses to recombinant nucleocapsid    proteins of five viral serotypes. J Clin Microbiol 1997; 35:1122-30.         [ Links ]20.- Wells R, Sosa S, Yadon Z et al. An unusual    Hantavirus outbreak in Southern Argentina: person to person transmission?. Emerg    Infect Dis 1997; 3: 171-4.         [ Links ]21.- Padula P J, Edelstein A, Miguel D L et    al. Hantavirus Pulmonary Syndrome outbreak in Argentina: Molecular evidence    for person to person transmission of Andes virus. Virology; 1998; 241: 323-30.          [ Links ]22.- Zaki S R, Greer P, Coffield L et al.    Hantavirus Pulmonary Syndrome. Pathogenesis of an emerging infectious diseases.    Am J Pathol; 1995; 146: 552-79.         [ Links ]23.- Hallin G, Simpson S, Crowell R et al.    Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med    1996; 24 (2): 252-8.         [ Links ]24.- Huggins J W, Hsiang C M, Cosgriff T M    et al. Prospective, double-blind, concurrent, placebo-controled clinical trial    of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J    Infect Dis 1991; 164: 1119-27.         [ Links ]25. Mertz G J, Hjelle B L, Williams T M, Koster    F T. Host responses in the Hantavirus Cardiopulmonary Syndrome. In: Saluzzo    JF, Dodet B, eds. Factors in the Emergence and Control of Rodent-Borne Viral    Diseases. Elsevier, Paris 1999; pp 133-7.         [ Links ]26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 

 9.- Levis S, Morzunov S, Rowe J et al. Genetic    diversity and epidemiology of hantavirus in Argentina. J Infect Dis 1998; 177:    529-38.         [ Links ]10.- Zaparolli M A, Iversson L B, Rosa M D    et al. Investigation on case contacts of human disease caused by hantavirus    in Juquitiba, State of Sao Paulo, Brazil. (abstr.) Am J Trop Med Hyg 1995; 53    (suppl): 439-         [ Links ]11.- Doyle T, Bryan R, Peters C J. Viral Hemorrhagic    Fevers and Hantavirus Infections in the Americas. Infect Dis Clin N A 1998;    12: 95-110.         [ Links ]12.- Centers for Diseases Control and Prevention    Hantavirus Pulmonary Syndrome-Chile 1997. MMWR 1997; 46: 949-51.         [ Links ]13.- Toro J, Vega J, Khan A et al. An outbreak    of hantavirus pulmonary syndrome, Chile 1997. Emerg Infect Dis 1998; 4: 667-702.          [ Links ]14.- Centers for Diseases Control and Prevention.    Hantavirus Pulmonary Syndrome - Panama 1999-2000. MMWR 2000; 49 (10): 205-7.          [ Links ]15.- Williams R J, Bryan R T, Mills J N. An    outbreak of Hantavirus Pulmonary Syndrome in Western Paraguay. Am J Trop Med    Hyg 1997; 57: 274-82.         [ Links ]16.- Johnson A M, Bowen M D, Ksiazek T G et    al. Laguna Negra virus associated with HPS in Western Paraguay and Bolivia.    Virology 1997; 238: 115-27.         [ Links ]17.- Espinoza R, Vial P, Noriega L M et al.    Hantavirus Pulmonary Syndrome in a Chilean patient with recent travel to Bolivia.    Emerg Infect Dis 1998; 4: 93-5.         [ Links ]18.- HJelle B, Jenison S, Torrez-Martinez    N et al. Rapid and specific detection of Sin Nombre virus antibodies in patients    with Hantavirus Pulmonary Syndrome by a strip immunoblot assay suitable for    field diagnosis. J Clin Microbiol 1997; 35: 600-8.         [ Links ]19.- Elgh F, Lundkvist A, Alexeyev A et al. Serological    diagnosis of Hantavirus infections by an enzyme-linked immunosorbent assay based    on detection of immunoglobulin G and M responses to recombinant nucleocapsid    proteins of five viral serotypes. J Clin Microbiol 1997; 35:1122-30.         [ Links ]20.- Wells R, Sosa S, Yadon Z et al. An unusual    Hantavirus outbreak in Southern Argentina: person to person transmission?. Emerg    Infect Dis 1997; 3: 171-4.         [ Links ]21.- Padula P J, Edelstein A, Miguel D L et    al. Hantavirus Pulmonary Syndrome outbreak in Argentina: Molecular evidence    for person to person transmission of Andes virus. Virology; 1998; 241: 323-30.          [ Links ]22.- Zaki S R, Greer P, Coffield L et al.    Hantavirus Pulmonary Syndrome. Pathogenesis of an emerging infectious diseases.    Am J Pathol; 1995; 146: 552-79.         [ Links ]23.- Hallin G, Simpson S, Crowell R et al.    Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med    1996; 24 (2): 252-8.         [ Links ]24.- Huggins J W, Hsiang C M, Cosgriff T M    et al. Prospective, double-blind, concurrent, placebo-controled clinical trial    of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J    Infect Dis 1991; 164: 1119-27.         [ Links ]25. Mertz G J, Hjelle B L, Williams T M, Koster    F T. Host responses in the Hantavirus Cardiopulmonary Syndrome. In: Saluzzo    JF, Dodet B, eds. Factors in the Emergence and Control of Rodent-Borne Viral    Diseases. Elsevier, Paris 1999; pp 133-7.         [ Links ]26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 

10.- Zaparolli M A, Iversson L B, Rosa M D    et al. Investigation on case contacts of human disease caused by hantavirus    in Juquitiba, State of Sao Paulo, Brazil. (abstr.) Am J Trop Med Hyg 1995; 53    (suppl): 439-         [ Links ]11.- Doyle T, Bryan R, Peters C J. Viral Hemorrhagic    Fevers and Hantavirus Infections in the Americas. Infect Dis Clin N A 1998;    12: 95-110.         [ Links ]12.- Centers for Diseases Control and Prevention    Hantavirus Pulmonary Syndrome-Chile 1997. MMWR 1997; 46: 949-51.         [ Links ]13.- Toro J, Vega J, Khan A et al. An outbreak    of hantavirus pulmonary syndrome, Chile 1997. Emerg Infect Dis 1998; 4: 667-702.          [ Links ]14.- Centers for Diseases Control and Prevention.    Hantavirus Pulmonary Syndrome - Panama 1999-2000. MMWR 2000; 49 (10): 205-7.          [ Links ]15.- Williams R J, Bryan R T, Mills J N. An    outbreak of Hantavirus Pulmonary Syndrome in Western Paraguay. Am J Trop Med    Hyg 1997; 57: 274-82.         [ Links ]16.- Johnson A M, Bowen M D, Ksiazek T G et    al. Laguna Negra virus associated with HPS in Western Paraguay and Bolivia.    Virology 1997; 238: 115-27.         [ Links ]17.- Espinoza R, Vial P, Noriega L M et al.    Hantavirus Pulmonary Syndrome in a Chilean patient with recent travel to Bolivia.    Emerg Infect Dis 1998; 4: 93-5.         [ Links ]18.- HJelle B, Jenison S, Torrez-Martinez    N et al. Rapid and specific detection of Sin Nombre virus antibodies in patients    with Hantavirus Pulmonary Syndrome by a strip immunoblot assay suitable for    field diagnosis. J Clin Microbiol 1997; 35: 600-8.         [ Links ]19.- Elgh F, Lundkvist A, Alexeyev A et al. Serological    diagnosis of Hantavirus infections by an enzyme-linked immunosorbent assay based    on detection of immunoglobulin G and M responses to recombinant nucleocapsid    proteins of five viral serotypes. J Clin Microbiol 1997; 35:1122-30.         [ Links ]20.- Wells R, Sosa S, Yadon Z et al. An unusual    Hantavirus outbreak in Southern Argentina: person to person transmission?. Emerg    Infect Dis 1997; 3: 171-4.         [ Links ]21.- Padula P J, Edelstein A, Miguel D L et    al. Hantavirus Pulmonary Syndrome outbreak in Argentina: Molecular evidence    for person to person transmission of Andes virus. Virology; 1998; 241: 323-30.          [ Links ]22.- Zaki S R, Greer P, Coffield L et al.    Hantavirus Pulmonary Syndrome. Pathogenesis of an emerging infectious diseases.    Am J Pathol; 1995; 146: 552-79.         [ Links ]23.- Hallin G, Simpson S, Crowell R et al.    Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med    1996; 24 (2): 252-8.         [ Links ]24.- Huggins J W, Hsiang C M, Cosgriff T M    et al. Prospective, double-blind, concurrent, placebo-controled clinical trial    of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J    Infect Dis 1991; 164: 1119-27.         [ Links ]25. Mertz G J, Hjelle B L, Williams T M, Koster    F T. Host responses in the Hantavirus Cardiopulmonary Syndrome. In: Saluzzo    JF, Dodet B, eds. Factors in the Emergence and Control of Rodent-Borne Viral    Diseases. Elsevier, Paris 1999; pp 133-7.         [ Links ]26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 

11.- Doyle T, Bryan R, Peters C J. Viral Hemorrhagic    Fevers and Hantavirus Infections in the Americas. Infect Dis Clin N A 1998;    12: 95-110.         [ Links ]12.- Centers for Diseases Control and Prevention    Hantavirus Pulmonary Syndrome-Chile 1997. MMWR 1997; 46: 949-51.         [ Links ]13.- Toro J, Vega J, Khan A et al. An outbreak    of hantavirus pulmonary syndrome, Chile 1997. Emerg Infect Dis 1998; 4: 667-702.          [ Links ]14.- Centers for Diseases Control and Prevention.    Hantavirus Pulmonary Syndrome - Panama 1999-2000. MMWR 2000; 49 (10): 205-7.          [ Links ]15.- Williams R J, Bryan R T, Mills J N. An    outbreak of Hantavirus Pulmonary Syndrome in Western Paraguay. Am J Trop Med    Hyg 1997; 57: 274-82.         [ Links ]16.- Johnson A M, Bowen M D, Ksiazek T G et    al. Laguna Negra virus associated with HPS in Western Paraguay and Bolivia.    Virology 1997; 238: 115-27.         [ Links ]17.- Espinoza R, Vial P, Noriega L M et al.    Hantavirus Pulmonary Syndrome in a Chilean patient with recent travel to Bolivia.    Emerg Infect Dis 1998; 4: 93-5.         [ Links ]18.- HJelle B, Jenison S, Torrez-Martinez    N et al. Rapid and specific detection of Sin Nombre virus antibodies in patients    with Hantavirus Pulmonary Syndrome by a strip immunoblot assay suitable for    field diagnosis. J Clin Microbiol 1997; 35: 600-8.         [ Links ]19.- Elgh F, Lundkvist A, Alexeyev A et al. Serological    diagnosis of Hantavirus infections by an enzyme-linked immunosorbent assay based    on detection of immunoglobulin G and M responses to recombinant nucleocapsid    proteins of five viral serotypes. J Clin Microbiol 1997; 35:1122-30.         [ Links ]20.- Wells R, Sosa S, Yadon Z et al. An unusual    Hantavirus outbreak in Southern Argentina: person to person transmission?. Emerg    Infect Dis 1997; 3: 171-4.         [ Links ]21.- Padula P J, Edelstein A, Miguel D L et    al. Hantavirus Pulmonary Syndrome outbreak in Argentina: Molecular evidence    for person to person transmission of Andes virus. Virology; 1998; 241: 323-30.          [ Links ]22.- Zaki S R, Greer P, Coffield L et al.    Hantavirus Pulmonary Syndrome. Pathogenesis of an emerging infectious diseases.    Am J Pathol; 1995; 146: 552-79.         [ Links ]23.- Hallin G, Simpson S, Crowell R et al.    Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med    1996; 24 (2): 252-8.         [ Links ]24.- Huggins J W, Hsiang C M, Cosgriff T M    et al. Prospective, double-blind, concurrent, placebo-controled clinical trial    of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J    Infect Dis 1991; 164: 1119-27.         [ Links ]25. Mertz G J, Hjelle B L, Williams T M, Koster    F T. Host responses in the Hantavirus Cardiopulmonary Syndrome. In: Saluzzo    JF, Dodet B, eds. Factors in the Emergence and Control of Rodent-Borne Viral    Diseases. Elsevier, Paris 1999; pp 133-7.         [ Links ]26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 

12.- Centers for Diseases Control and Prevention    Hantavirus Pulmonary Syndrome-Chile 1997. MMWR 1997; 46: 949-51.         [ Links ]13.- Toro J, Vega J, Khan A et al. An outbreak    of hantavirus pulmonary syndrome, Chile 1997. Emerg Infect Dis 1998; 4: 667-702.          [ Links ]14.- Centers for Diseases Control and Prevention.    Hantavirus Pulmonary Syndrome - Panama 1999-2000. MMWR 2000; 49 (10): 205-7.          [ Links ]15.- Williams R J, Bryan R T, Mills J N. An    outbreak of Hantavirus Pulmonary Syndrome in Western Paraguay. Am J Trop Med    Hyg 1997; 57: 274-82.         [ Links ]16.- Johnson A M, Bowen M D, Ksiazek T G et    al. Laguna Negra virus associated with HPS in Western Paraguay and Bolivia.    Virology 1997; 238: 115-27.         [ Links ]17.- Espinoza R, Vial P, Noriega L M et al.    Hantavirus Pulmonary Syndrome in a Chilean patient with recent travel to Bolivia.    Emerg Infect Dis 1998; 4: 93-5.         [ Links ]18.- HJelle B, Jenison S, Torrez-Martinez    N et al. Rapid and specific detection of Sin Nombre virus antibodies in patients    with Hantavirus Pulmonary Syndrome by a strip immunoblot assay suitable for    field diagnosis. J Clin Microbiol 1997; 35: 600-8.         [ Links ]19.- Elgh F, Lundkvist A, Alexeyev A et al. Serological    diagnosis of Hantavirus infections by an enzyme-linked immunosorbent assay based    on detection of immunoglobulin G and M responses to recombinant nucleocapsid    proteins of five viral serotypes. J Clin Microbiol 1997; 35:1122-30.         [ Links ]20.- Wells R, Sosa S, Yadon Z et al. An unusual    Hantavirus outbreak in Southern Argentina: person to person transmission?. Emerg    Infect Dis 1997; 3: 171-4.         [ Links ]21.- Padula P J, Edelstein A, Miguel D L et    al. Hantavirus Pulmonary Syndrome outbreak in Argentina: Molecular evidence    for person to person transmission of Andes virus. Virology; 1998; 241: 323-30.          [ Links ]22.- Zaki S R, Greer P, Coffield L et al.    Hantavirus Pulmonary Syndrome. Pathogenesis of an emerging infectious diseases.    Am J Pathol; 1995; 146: 552-79.         [ Links ]23.- Hallin G, Simpson S, Crowell R et al.    Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med    1996; 24 (2): 252-8.         [ Links ]24.- Huggins J W, Hsiang C M, Cosgriff T M    et al. Prospective, double-blind, concurrent, placebo-controled clinical trial    of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J    Infect Dis 1991; 164: 1119-27.         [ Links ]25. Mertz G J, Hjelle B L, Williams T M, Koster    F T. Host responses in the Hantavirus Cardiopulmonary Syndrome. In: Saluzzo    JF, Dodet B, eds. Factors in the Emergence and Control of Rodent-Borne Viral    Diseases. Elsevier, Paris 1999; pp 133-7.         [ Links ]26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 

13.- Toro J, Vega J, Khan A et al. An outbreak    of hantavirus pulmonary syndrome, Chile 1997. Emerg Infect Dis 1998; 4: 667-702.          [ Links ]14.- Centers for Diseases Control and Prevention.    Hantavirus Pulmonary Syndrome - Panama 1999-2000. MMWR 2000; 49 (10): 205-7.          [ Links ]15.- Williams R J, Bryan R T, Mills J N. An    outbreak of Hantavirus Pulmonary Syndrome in Western Paraguay. Am J Trop Med    Hyg 1997; 57: 274-82.         [ Links ]16.- Johnson A M, Bowen M D, Ksiazek T G et    al. Laguna Negra virus associated with HPS in Western Paraguay and Bolivia.    Virology 1997; 238: 115-27.         [ Links ]17.- Espinoza R, Vial P, Noriega L M et al.    Hantavirus Pulmonary Syndrome in a Chilean patient with recent travel to Bolivia.    Emerg Infect Dis 1998; 4: 93-5.         [ Links ]18.- HJelle B, Jenison S, Torrez-Martinez    N et al. Rapid and specific detection of Sin Nombre virus antibodies in patients    with Hantavirus Pulmonary Syndrome by a strip immunoblot assay suitable for    field diagnosis. J Clin Microbiol 1997; 35: 600-8.         [ Links ]19.- Elgh F, Lundkvist A, Alexeyev A et al. Serological    diagnosis of Hantavirus infections by an enzyme-linked immunosorbent assay based    on detection of immunoglobulin G and M responses to recombinant nucleocapsid    proteins of five viral serotypes. J Clin Microbiol 1997; 35:1122-30.         [ Links ]20.- Wells R, Sosa S, Yadon Z et al. An unusual    Hantavirus outbreak in Southern Argentina: person to person transmission?. Emerg    Infect Dis 1997; 3: 171-4.         [ Links ]21.- Padula P J, Edelstein A, Miguel D L et    al. Hantavirus Pulmonary Syndrome outbreak in Argentina: Molecular evidence    for person to person transmission of Andes virus. Virology; 1998; 241: 323-30.          [ Links ]22.- Zaki S R, Greer P, Coffield L et al.    Hantavirus Pulmonary Syndrome. Pathogenesis of an emerging infectious diseases.    Am J Pathol; 1995; 146: 552-79.         [ Links ]23.- Hallin G, Simpson S, Crowell R et al.    Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med    1996; 24 (2): 252-8.         [ Links ]24.- Huggins J W, Hsiang C M, Cosgriff T M    et al. Prospective, double-blind, concurrent, placebo-controled clinical trial    of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J    Infect Dis 1991; 164: 1119-27.         [ Links ]25. Mertz G J, Hjelle B L, Williams T M, Koster    F T. Host responses in the Hantavirus Cardiopulmonary Syndrome. In: Saluzzo    JF, Dodet B, eds. Factors in the Emergence and Control of Rodent-Borne Viral    Diseases. Elsevier, Paris 1999; pp 133-7.         [ Links ]26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 

14.- Centers for Diseases Control and Prevention.    Hantavirus Pulmonary Syndrome - Panama 1999-2000. MMWR 2000; 49 (10): 205-7.          [ Links ]15.- Williams R J, Bryan R T, Mills J N. An    outbreak of Hantavirus Pulmonary Syndrome in Western Paraguay. Am J Trop Med    Hyg 1997; 57: 274-82.         [ Links ]16.- Johnson A M, Bowen M D, Ksiazek T G et    al. Laguna Negra virus associated with HPS in Western Paraguay and Bolivia.    Virology 1997; 238: 115-27.         [ Links ]17.- Espinoza R, Vial P, Noriega L M et al.    Hantavirus Pulmonary Syndrome in a Chilean patient with recent travel to Bolivia.    Emerg Infect Dis 1998; 4: 93-5.         [ Links ]18.- HJelle B, Jenison S, Torrez-Martinez    N et al. Rapid and specific detection of Sin Nombre virus antibodies in patients    with Hantavirus Pulmonary Syndrome by a strip immunoblot assay suitable for    field diagnosis. J Clin Microbiol 1997; 35: 600-8.         [ Links ]19.- Elgh F, Lundkvist A, Alexeyev A et al. Serological    diagnosis of Hantavirus infections by an enzyme-linked immunosorbent assay based    on detection of immunoglobulin G and M responses to recombinant nucleocapsid    proteins of five viral serotypes. J Clin Microbiol 1997; 35:1122-30.         [ Links ]20.- Wells R, Sosa S, Yadon Z et al. An unusual    Hantavirus outbreak in Southern Argentina: person to person transmission?. Emerg    Infect Dis 1997; 3: 171-4.         [ Links ]21.- Padula P J, Edelstein A, Miguel D L et    al. Hantavirus Pulmonary Syndrome outbreak in Argentina: Molecular evidence    for person to person transmission of Andes virus. Virology; 1998; 241: 323-30.          [ Links ]22.- Zaki S R, Greer P, Coffield L et al.    Hantavirus Pulmonary Syndrome. Pathogenesis of an emerging infectious diseases.    Am J Pathol; 1995; 146: 552-79.         [ Links ]23.- Hallin G, Simpson S, Crowell R et al.    Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med    1996; 24 (2): 252-8.         [ Links ]24.- Huggins J W, Hsiang C M, Cosgriff T M    et al. Prospective, double-blind, concurrent, placebo-controled clinical trial    of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J    Infect Dis 1991; 164: 1119-27.         [ Links ]25. Mertz G J, Hjelle B L, Williams T M, Koster    F T. Host responses in the Hantavirus Cardiopulmonary Syndrome. In: Saluzzo    JF, Dodet B, eds. Factors in the Emergence and Control of Rodent-Borne Viral    Diseases. Elsevier, Paris 1999; pp 133-7.         [ Links ]26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 

15.- Williams R J, Bryan R T, Mills J N. An    outbreak of Hantavirus Pulmonary Syndrome in Western Paraguay. Am J Trop Med    Hyg 1997; 57: 274-82.         [ Links ]16.- Johnson A M, Bowen M D, Ksiazek T G et    al. Laguna Negra virus associated with HPS in Western Paraguay and Bolivia.    Virology 1997; 238: 115-27.         [ Links ]17.- Espinoza R, Vial P, Noriega L M et al.    Hantavirus Pulmonary Syndrome in a Chilean patient with recent travel to Bolivia.    Emerg Infect Dis 1998; 4: 93-5.         [ Links ]18.- HJelle B, Jenison S, Torrez-Martinez    N et al. Rapid and specific detection of Sin Nombre virus antibodies in patients    with Hantavirus Pulmonary Syndrome by a strip immunoblot assay suitable for    field diagnosis. J Clin Microbiol 1997; 35: 600-8.         [ Links ]19.- Elgh F, Lundkvist A, Alexeyev A et al. Serological    diagnosis of Hantavirus infections by an enzyme-linked immunosorbent assay based    on detection of immunoglobulin G and M responses to recombinant nucleocapsid    proteins of five viral serotypes. J Clin Microbiol 1997; 35:1122-30.         [ Links ]20.- Wells R, Sosa S, Yadon Z et al. An unusual    Hantavirus outbreak in Southern Argentina: person to person transmission?. Emerg    Infect Dis 1997; 3: 171-4.         [ Links ]21.- Padula P J, Edelstein A, Miguel D L et    al. Hantavirus Pulmonary Syndrome outbreak in Argentina: Molecular evidence    for person to person transmission of Andes virus. Virology; 1998; 241: 323-30.          [ Links ]22.- Zaki S R, Greer P, Coffield L et al.    Hantavirus Pulmonary Syndrome. Pathogenesis of an emerging infectious diseases.    Am J Pathol; 1995; 146: 552-79.         [ Links ]23.- Hallin G, Simpson S, Crowell R et al.    Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med    1996; 24 (2): 252-8.         [ Links ]24.- Huggins J W, Hsiang C M, Cosgriff T M    et al. Prospective, double-blind, concurrent, placebo-controled clinical trial    of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J    Infect Dis 1991; 164: 1119-27.         [ Links ]25. Mertz G J, Hjelle B L, Williams T M, Koster    F T. Host responses in the Hantavirus Cardiopulmonary Syndrome. In: Saluzzo    JF, Dodet B, eds. Factors in the Emergence and Control of Rodent-Borne Viral    Diseases. Elsevier, Paris 1999; pp 133-7.         [ Links ]26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 

16.- Johnson A M, Bowen M D, Ksiazek T G et    al. Laguna Negra virus associated with HPS in Western Paraguay and Bolivia.    Virology 1997; 238: 115-27.         [ Links ]17.- Espinoza R, Vial P, Noriega L M et al.    Hantavirus Pulmonary Syndrome in a Chilean patient with recent travel to Bolivia.    Emerg Infect Dis 1998; 4: 93-5.         [ Links ]18.- HJelle B, Jenison S, Torrez-Martinez    N et al. Rapid and specific detection of Sin Nombre virus antibodies in patients    with Hantavirus Pulmonary Syndrome by a strip immunoblot assay suitable for    field diagnosis. J Clin Microbiol 1997; 35: 600-8.         [ Links ]19.- Elgh F, Lundkvist A, Alexeyev A et al. Serological    diagnosis of Hantavirus infections by an enzyme-linked immunosorbent assay based    on detection of immunoglobulin G and M responses to recombinant nucleocapsid    proteins of five viral serotypes. J Clin Microbiol 1997; 35:1122-30.         [ Links ]20.- Wells R, Sosa S, Yadon Z et al. An unusual    Hantavirus outbreak in Southern Argentina: person to person transmission?. Emerg    Infect Dis 1997; 3: 171-4.         [ Links ]21.- Padula P J, Edelstein A, Miguel D L et    al. Hantavirus Pulmonary Syndrome outbreak in Argentina: Molecular evidence    for person to person transmission of Andes virus. Virology; 1998; 241: 323-30.          [ Links ]22.- Zaki S R, Greer P, Coffield L et al.    Hantavirus Pulmonary Syndrome. Pathogenesis of an emerging infectious diseases.    Am J Pathol; 1995; 146: 552-79.         [ Links ]23.- Hallin G, Simpson S, Crowell R et al.    Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med    1996; 24 (2): 252-8.         [ Links ]24.- Huggins J W, Hsiang C M, Cosgriff T M    et al. Prospective, double-blind, concurrent, placebo-controled clinical trial    of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J    Infect Dis 1991; 164: 1119-27.         [ Links ]25. Mertz G J, Hjelle B L, Williams T M, Koster    F T. Host responses in the Hantavirus Cardiopulmonary Syndrome. In: Saluzzo    JF, Dodet B, eds. Factors in the Emergence and Control of Rodent-Borne Viral    Diseases. Elsevier, Paris 1999; pp 133-7.         [ Links ]26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 

17.- Espinoza R, Vial P, Noriega L M et al.    Hantavirus Pulmonary Syndrome in a Chilean patient with recent travel to Bolivia.    Emerg Infect Dis 1998; 4: 93-5.         [ Links ]18.- HJelle B, Jenison S, Torrez-Martinez    N et al. Rapid and specific detection of Sin Nombre virus antibodies in patients    with Hantavirus Pulmonary Syndrome by a strip immunoblot assay suitable for    field diagnosis. J Clin Microbiol 1997; 35: 600-8.         [ Links ]19.- Elgh F, Lundkvist A, Alexeyev A et al. Serological    diagnosis of Hantavirus infections by an enzyme-linked immunosorbent assay based    on detection of immunoglobulin G and M responses to recombinant nucleocapsid    proteins of five viral serotypes. J Clin Microbiol 1997; 35:1122-30.         [ Links ]20.- Wells R, Sosa S, Yadon Z et al. An unusual    Hantavirus outbreak in Southern Argentina: person to person transmission?. Emerg    Infect Dis 1997; 3: 171-4.         [ Links ]21.- Padula P J, Edelstein A, Miguel D L et    al. Hantavirus Pulmonary Syndrome outbreak in Argentina: Molecular evidence    for person to person transmission of Andes virus. Virology; 1998; 241: 323-30.          [ Links ]22.- Zaki S R, Greer P, Coffield L et al.    Hantavirus Pulmonary Syndrome. Pathogenesis of an emerging infectious diseases.    Am J Pathol; 1995; 146: 552-79.         [ Links ]23.- Hallin G, Simpson S, Crowell R et al.    Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med    1996; 24 (2): 252-8.         [ Links ]24.- Huggins J W, Hsiang C M, Cosgriff T M    et al. Prospective, double-blind, concurrent, placebo-controled clinical trial    of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J    Infect Dis 1991; 164: 1119-27.         [ Links ]25. Mertz G J, Hjelle B L, Williams T M, Koster    F T. Host responses in the Hantavirus Cardiopulmonary Syndrome. In: Saluzzo    JF, Dodet B, eds. Factors in the Emergence and Control of Rodent-Borne Viral    Diseases. Elsevier, Paris 1999; pp 133-7.         [ Links ]26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 

18.- HJelle B, Jenison S, Torrez-Martinez    N et al. Rapid and specific detection of Sin Nombre virus antibodies in patients    with Hantavirus Pulmonary Syndrome by a strip immunoblot assay suitable for    field diagnosis. J Clin Microbiol 1997; 35: 600-8.         [ Links ]19.- Elgh F, Lundkvist A, Alexeyev A et al. Serological    diagnosis of Hantavirus infections by an enzyme-linked immunosorbent assay based    on detection of immunoglobulin G and M responses to recombinant nucleocapsid    proteins of five viral serotypes. J Clin Microbiol 1997; 35:1122-30.         [ Links ]20.- Wells R, Sosa S, Yadon Z et al. An unusual    Hantavirus outbreak in Southern Argentina: person to person transmission?. Emerg    Infect Dis 1997; 3: 171-4.         [ Links ]21.- Padula P J, Edelstein A, Miguel D L et    al. Hantavirus Pulmonary Syndrome outbreak in Argentina: Molecular evidence    for person to person transmission of Andes virus. Virology; 1998; 241: 323-30.          [ Links ]22.- Zaki S R, Greer P, Coffield L et al.    Hantavirus Pulmonary Syndrome. Pathogenesis of an emerging infectious diseases.    Am J Pathol; 1995; 146: 552-79.         [ Links ]23.- Hallin G, Simpson S, Crowell R et al.    Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med    1996; 24 (2): 252-8.         [ Links ]24.- Huggins J W, Hsiang C M, Cosgriff T M    et al. Prospective, double-blind, concurrent, placebo-controled clinical trial    of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J    Infect Dis 1991; 164: 1119-27.         [ Links ]25. Mertz G J, Hjelle B L, Williams T M, Koster    F T. Host responses in the Hantavirus Cardiopulmonary Syndrome. In: Saluzzo    JF, Dodet B, eds. Factors in the Emergence and Control of Rodent-Borne Viral    Diseases. Elsevier, Paris 1999; pp 133-7.         [ Links ]26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 

19.- Elgh F, Lundkvist A, Alexeyev A et al. Serological    diagnosis of Hantavirus infections by an enzyme-linked immunosorbent assay based    on detection of immunoglobulin G and M responses to recombinant nucleocapsid    proteins of five viral serotypes. J Clin Microbiol 1997; 35:1122-30.         [ Links ]20.- Wells R, Sosa S, Yadon Z et al. An unusual    Hantavirus outbreak in Southern Argentina: person to person transmission?. Emerg    Infect Dis 1997; 3: 171-4.         [ Links ]21.- Padula P J, Edelstein A, Miguel D L et    al. Hantavirus Pulmonary Syndrome outbreak in Argentina: Molecular evidence    for person to person transmission of Andes virus. Virology; 1998; 241: 323-30.          [ Links ]22.- Zaki S R, Greer P, Coffield L et al.    Hantavirus Pulmonary Syndrome. Pathogenesis of an emerging infectious diseases.    Am J Pathol; 1995; 146: 552-79.         [ Links ]23.- Hallin G, Simpson S, Crowell R et al.    Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med    1996; 24 (2): 252-8.         [ Links ]24.- Huggins J W, Hsiang C M, Cosgriff T M    et al. Prospective, double-blind, concurrent, placebo-controled clinical trial    of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J    Infect Dis 1991; 164: 1119-27.         [ Links ]25. Mertz G J, Hjelle B L, Williams T M, Koster    F T. Host responses in the Hantavirus Cardiopulmonary Syndrome. In: Saluzzo    JF, Dodet B, eds. Factors in the Emergence and Control of Rodent-Borne Viral    Diseases. Elsevier, Paris 1999; pp 133-7.         [ Links ]26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 

20.- Wells R, Sosa S, Yadon Z et al. An unusual    Hantavirus outbreak in Southern Argentina: person to person transmission?. Emerg    Infect Dis 1997; 3: 171-4.         [ Links ]21.- Padula P J, Edelstein A, Miguel D L et    al. Hantavirus Pulmonary Syndrome outbreak in Argentina: Molecular evidence    for person to person transmission of Andes virus. Virology; 1998; 241: 323-30.          [ Links ]22.- Zaki S R, Greer P, Coffield L et al.    Hantavirus Pulmonary Syndrome. Pathogenesis of an emerging infectious diseases.    Am J Pathol; 1995; 146: 552-79.         [ Links ]23.- Hallin G, Simpson S, Crowell R et al.    Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med    1996; 24 (2): 252-8.         [ Links ]24.- Huggins J W, Hsiang C M, Cosgriff T M    et al. Prospective, double-blind, concurrent, placebo-controled clinical trial    of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J    Infect Dis 1991; 164: 1119-27.         [ Links ]25. Mertz G J, Hjelle B L, Williams T M, Koster    F T. Host responses in the Hantavirus Cardiopulmonary Syndrome. In: Saluzzo    JF, Dodet B, eds. Factors in the Emergence and Control of Rodent-Borne Viral    Diseases. Elsevier, Paris 1999; pp 133-7.         [ Links ]26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 

21.- Padula P J, Edelstein A, Miguel D L et    al. Hantavirus Pulmonary Syndrome outbreak in Argentina: Molecular evidence    for person to person transmission of Andes virus. Virology; 1998; 241: 323-30.          [ Links ]22.- Zaki S R, Greer P, Coffield L et al.    Hantavirus Pulmonary Syndrome. Pathogenesis of an emerging infectious diseases.    Am J Pathol; 1995; 146: 552-79.         [ Links ]23.- Hallin G, Simpson S, Crowell R et al.    Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med    1996; 24 (2): 252-8.         [ Links ]24.- Huggins J W, Hsiang C M, Cosgriff T M    et al. Prospective, double-blind, concurrent, placebo-controled clinical trial    of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J    Infect Dis 1991; 164: 1119-27.         [ Links ]25. Mertz G J, Hjelle B L, Williams T M, Koster    F T. Host responses in the Hantavirus Cardiopulmonary Syndrome. In: Saluzzo    JF, Dodet B, eds. Factors in the Emergence and Control of Rodent-Borne Viral    Diseases. Elsevier, Paris 1999; pp 133-7.         [ Links ]26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 

22.- Zaki S R, Greer P, Coffield L et al.    Hantavirus Pulmonary Syndrome. Pathogenesis of an emerging infectious diseases.    Am J Pathol; 1995; 146: 552-79.         [ Links ]23.- Hallin G, Simpson S, Crowell R et al.    Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med    1996; 24 (2): 252-8.         [ Links ]24.- Huggins J W, Hsiang C M, Cosgriff T M    et al. Prospective, double-blind, concurrent, placebo-controled clinical trial    of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J    Infect Dis 1991; 164: 1119-27.         [ Links ]25. Mertz G J, Hjelle B L, Williams T M, Koster    F T. Host responses in the Hantavirus Cardiopulmonary Syndrome. In: Saluzzo    JF, Dodet B, eds. Factors in the Emergence and Control of Rodent-Borne Viral    Diseases. Elsevier, Paris 1999; pp 133-7.         [ Links ]26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 

23.- Hallin G, Simpson S, Crowell R et al.    Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med    1996; 24 (2): 252-8.         [ Links ]24.- Huggins J W, Hsiang C M, Cosgriff T M    et al. Prospective, double-blind, concurrent, placebo-controled clinical trial    of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J    Infect Dis 1991; 164: 1119-27.         [ Links ]25. Mertz G J, Hjelle B L, Williams T M, Koster    F T. Host responses in the Hantavirus Cardiopulmonary Syndrome. In: Saluzzo    JF, Dodet B, eds. Factors in the Emergence and Control of Rodent-Borne Viral    Diseases. Elsevier, Paris 1999; pp 133-7.         [ Links ]26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 

24.- Huggins J W, Hsiang C M, Cosgriff T M    et al. Prospective, double-blind, concurrent, placebo-controled clinical trial    of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J    Infect Dis 1991; 164: 1119-27.         [ Links ]25. Mertz G J, Hjelle B L, Williams T M, Koster    F T. Host responses in the Hantavirus Cardiopulmonary Syndrome. In: Saluzzo    JF, Dodet B, eds. Factors in the Emergence and Control of Rodent-Borne Viral    Diseases. Elsevier, Paris 1999; pp 133-7.         [ Links ]26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 

25. Mertz G J, Hjelle B L, Williams T M, Koster    F T. Host responses in the Hantavirus Cardiopulmonary Syndrome. In: Saluzzo    JF, Dodet B, eds. Factors in the Emergence and Control of Rodent-Borne Viral    Diseases. Elsevier, Paris 1999; pp 133-7.         [ Links ]26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 

26.- Bharadwaj M, Nofchissy R, Goade D, Koster    F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome.    J Infect Dis 2000;182:43-8.         [ Links ] 